Rosa Chiara Paolicelli's team at the Department of Biomedical Sciences of Unil uncovered a new role for the TDP-43 protein in ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to VCA-894A, Vanda's investigational ...

Early recognition of cervical spine disorders and timely evaluation help prevent permanent neurological damage, improve ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted ...

DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced the appointment of Michael Snitkovsky as chief operations officer, adding a ...

As a coauthor of this column for a number of years now, I have covered the topic of disability insurance in the past. As all ...

Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...

Prilenia Therapeutics B.V. and Ferreri today announced initiation of the confirmatory PRECISE-HD study (Pridopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington's Disease (HD) ...

Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 ...

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...

Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol - - FDA agreed that a single pivotal Phase 3 trial ...

Clinician-led engagement outperforms non-clinical call-center models, with “nurse ambassador” programs enabling escalation, ...